Britain may restrict heart pump use

Nov 29, 2006

British researchers are urging the restricted use of an implantable pump designed to help heart failure patients while they wait for a transplant.

"Although we believe that the devices have been developed sufficiently to prolong life for some very sick patients who have rapidly deteriorating heart failure, we don't feel they've been developed quite enough yet for widespread use among the whole heart failure population," said lead researcher Linda Sharples of Britain's National Health Service.

Sharples studied health outcomes and the cost effectiveness of the ventricular assist devices for 70 British patients who received the implant between April 2002 and December 2004.

"We compared the VAD group with the very sickest of the transplant candidates and found the healthcare for those individuals was less costly. Those non-VAD patients also had greater survival," Sharples said.

"We recommend that the United Kingdom continue to monitor the development of the new devices," said Sharples. "I think we are all quite hopeful that they will progress and we will have more cost-effective and effective devices in the future."

The review appears in the latest issue of Health Technology Assessment.

Copyright 2006 by United Press International

Explore further: Court clears German safety body in breast implant scare

Related Stories

Major step for implantable drug-delivery device

Jun 29, 2015

An implantable, microchip-based device may soon replace the injections and pills now needed to treat chronic diseases: Earlier this month, MIT spinout Microchips Biotech partnered with a pharmaceutical giant ...

Heartbeat on a chip could improve pharmaceutical tests

Jun 17, 2015

A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms, ...

Mimicking the body on a chip for new drug testing

Jun 10, 2015

Scientists in an EU project have developed a microfluidic chip that simultaneously analyses the reactions of several human organ tissues when they come into contact with candidates for new drugs. The ground-breaking ...

Recommended for you

Drug and device firms paid $6.5B to care providers

Jun 30, 2015

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.